Moreover, T1D risk may be related to how an HLA-DQ genotype determines the balance of T-cell inflammatory versus regulatory responses to insulin, having implications for insulin-specific therapies to prevent T1D (ref. 31). This evidence concerns the gene INS and type 1 diabetes mellitus.